Delivery Order #SPE2DP26F3268

Delivery Order for Cetirizine Hydrochloride Under Long-Term Pharmaceutical IDV

This award is a delivery order contract under an existing long-term indefinite delivery vehicle (IDV) pharmaceutical supply agreement. The recipient, DMS Pharmaceutical Group Inc., a distributor specializing in pharmaceutical products, is tasked with providing a critical medication, cetirizine hydrochloride. This product is an important antihistamine drug used to treat allergy symptoms, making its supply crucial for supporting public health initiatives of federal agencies. The scope of this delivery order encompasses the procurement and delivery of cetirizine hydrochloride within a short timeframe, reflecting ongoing demand fulfillment under the broader definitive pharmaceutical contract. This order builds on the strategic multi-year contract awarded previously to DMS Pharmaceutical Group, underscoring consistent and reliable access to essential medications. The contract was likely awarded through competitive processes embedded in the original IDV award. The performance period for this delivery order is a brief, focused interval within a larger multi-year commitment, ensuring timely delivery to meet immediate agency needs.

Description

8511952550!CETIRIZINE HYDROCHL

View original record